COPD prevalence study in Portugal
Part of Lungs & breathing clinical trials.
This study is looking for people living in Portugal to find out how many have COPD (a lung condition). You will do a simple breathing test to check your lung health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 20 years or older.
- You must live in Portugal and have lived there for at least one year.
- You must be able to do a spirometry breathing test (blowing into a tube).
- You must not have severe cognitive problems that could interfere with participation.
- You must sign a consent form agreeing to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who currently smoke and people who may have newly found COPD (chronic obstructive lung disease) based on breathing test results. It aims to better understand lung disease in real life and what it means for health over time.
This trial looks at how long-term health conditions like heart disease, diabetes, or high blood pressure might affect breathing problems. The goal is to better understand and help people with both issues.
This study looks at the health of Brazilian adults with COPD. It aims to understand how the condition affects people and may help improve future treatments.
This study follows people with severe or very severe COPD to learn more about their health over time. You may qualify if your COPD causes many symptoms or frequent flare-ups.
This study looks at how chronic lung disease relates to other health conditions in people receiving care at primary health clinics in Brazil. It will test a new approach to identify and help patients with multiple health problems.
This study follows people with severe COPD to learn more about their condition over time. It may help doctors understand how to better care for patients with advanced COPD.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.